ChemicalBook >> journal list>> Pharmaceutics

Pharmaceutics

IF:4.9 CiteScore:7.9 Articles:2379

Pharmaceutics (ISSN 1999-4923) is an open access journal which provides an advanced forum for the science and technology of pharmaceutics and biopharmaceutics. It publishes reviews, regular research papers, communications, and short notes. Covered topics include pharmacokinetics, toxicokinetics, pharmacodynamics, pharmacogenetics and pharmacogenomics, and pharmaceutical formulation. Our aim is to encourage scientists to publish their experimental and theoretical details in as much detail as possible. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced.

Drug Combinations Targeting FAK and MEK Overcomes Tumor Heterogeneity in Glioblastoma

Published: 23 April 2025 DOI: 10.3390/pharmaceutics17050549
Muhammad Furqan, Richard J R Elliott, Peter W K Nagle, John C Dawson, Roza Masalmeh, Virginia Alvarez Garcia, Alison F Munro, Camilla Drake, Gillian M Morrison, Steven M Pollard, Daniel Ebner, Valerie G Brunton, Margaret C Frame, Neil O Carragher

High Manganese Content of Lipid NanoMn (LNM) by Microfluidic Technology for Enhancing Anti-Tumor Immunity

Published: 19 April 2024 DOI: 10.3390/pharmaceutics16040556
Jiawei Sun, Jingjing Gong, Lidong Gong, Chuanda Zhu, Longhao Li-Yang, Jingya Wang, Yuanyuan Yang, Shiming Zhang, Silu Liu, Ji-Jun Fu, Pengcheng Xu

Solid Lipid Nanoparticles Enhancing the Leishmanicidal Activity of Delamanid

Published: 27 December 2023 DOI: 10.3390/pharmaceutics16010041
Javier Santamaría-Aguirre, Daniela Jacho, Miguel A. Méndez, Ana Poveda, Javier Carrión, Mónica L. Fanarraga

Antibacterial, Anti-Biofilm and Pro-Migratory Effects of Double Layered Hydrogels Packaged with Lactoferrin-DsiRNA-Silver Nanoparticles for Chronic Wound Therapy

Published: 19 March 2023 DOI: 10.3390/pharmaceutics15030991
Mohammad Aqil M Fathil, Haliza Katas

Naringin: Nanotechnological Strategies for Potential Pharmaceutical Applications.

Published: 7 March 2023 DOI: 10.3390/pharmaceutics15030863
Soledad Ravetti, Ariel G Garro, Agustina Gaitán, Mariano Murature, Mariela Galiano, Sofía G Brignone, Santiago D Palma

The Trimeric Artesunate Analog TF27, a Broadly Acting Anti-Infective Model Drug, Exerts Pronounced Anti-SARS-CoV-2 Activity Spanning Variants and Host Cell Types

Published: 29 December 2022 DOI: 10.3390/pharmaceutics15010115
Friedrich Hahn, Christina Wangen, Sigrun Häge, Lars Herrmann, Alexandra Herrmann, Svetlana B Tsogoeva, Manfred Marschall

The Translational Landscape Revealed the Sequential Treatment Containing ATRA plus PI3K/AKT Inhibitors as an Efficient Strategy for AML Therapy

Published: 28 October 2022 DOI: 10.3390/pharmaceutics14112329
Ke Wang, Ziyao Ou, Ge Deng, Shufang Li, Jingjing Su, Yayun Xu, Renpeng Zhou, Wei Hu, Feihu Chen

ABCB1 and ABCG2 Control Brain Accumulation and Intestinal Disposition of the Novel ROS1/TRK/ALK Inhibitor Repotrectinib, While OATP1A/1B, ABCG2, and CYP3A Limit Its Oral Availability

Published: 21 October 2021 DOI: 10.3390/pharmaceutics13111761
Wenlong Li, Rolf W Sparidans, Maria C Lebre, Jos H Beijnen, Alfred H Schinkel

Structural Characterization of the Millennial Antibacterial (Fluoro)Quinolones—Shaping the Fifth Generation

Published: 18 August 2021 DOI: 10.3390/pharmaceutics13081289
Aura Rusu, Ioana-Andreea Lungu, Octavia-Laura Moldovan, Corneliu Tanase, Gabriel Hancu